94-17063. Announcement of Cooperative Agreement to the World Health Organization  

  • [Federal Register Volume 59, Number 134 (Thursday, July 14, 1994)]
    [Unknown Section]
    [Page 0]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 94-17063]
    
    
    [[Page Unknown]]
    
    [Federal Register: July 14, 1994]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    [CDC-458]
    
     
    
    Announcement of Cooperative Agreement to the World Health 
    Organization
    
    Summary
    
        The Centers for Disease Control and Prevention (CDC) announces the 
    availability of fiscal year (FY) 1994 funds for a sole source 
    cooperative agreement with the World Health Organization (WHO) for 
    Hantavirus Pulmonary Syndrome (HPS) research in epidemiology, 
    pathogenesis and vaccine development. The activities are intended to 
    strengthen the knowledge base of the epidemiology and pathogenesis of 
    hantaviruses, improve diagnostics capabilities, and assist in the 
    further development of a hantavirus vaccine. These programs will 
    provide information for public policy and for targeting strategies for 
    hantavirus-associated respiratory disease prevention and treatment 
    programs. Approximately $60,000 is available in FY 1994 to fund one 
    award. It is expected that the award will begin on or about September 
    30, 1994, and will be made for a 12-month budget period within a 
    project period of up to two years. Funding estimates may vary and are 
    subject to change. A continuation award within an approved project 
    period will be made on the basis of satisfactory progress and 
    availability of funds.
        The purpose for this program is to assist research on hantaviruses 
    that will help researchers in the U.S. to understand the epidemiology 
    and mechanisms of immunity and immunopathology of hantavirus infection. 
    It is also intended that the agreement assure that proper observations 
    of vaccine trials are reliably made should further vaccine development 
    be necessary in this country.
    
        The Public Health Service (PHS) is committed to achieving the 
    health promotion and disease prevention objectives of Healthy People 
    2000, a PHS-led national activity to reduce morbidity and mortality and 
    improve the quality of life. This announcement is related to the 
    priority area of Immunization and Infectious Diseases. (For ordering a 
    copy of Healthy People 2000, see the Section Where to Obtain Additional 
    Information.)
    
    Authority
    
        This program is authorized under section 301(a) (42 U.S.C. 241(a)), 
    311 (42 U.S.C. 243), and 317(k)(3)(42 U.S.C. 247b(k)(3)) of the Public 
    Health Service Act, as amended, Pub. L. 95-626. Applicable program 
    regulations are found in 42 CFR part 52, Grants for Research Projects.
    
    Smoke-Free Workplace
    
        The Public Health Service strongly encourages all grant recipients 
    to provide a smoke-free workplace and promote the non-use of all 
    tobacco products. This is consistent with the PHS mission to protect 
    and advance the physical and mental health of the American people.
    
    Eligible Applicant
    
        Assistance will be provided only to the World Health Organization 
    (WHO). No other applications are solicited. The program announcement 
    and application kit have been sent to WHO.
    
        WHO is the coordinating agency for WHO Regional Offices including 
    Pan American Health Organization (PAHO), European Regional Office 
    (EURO), South East Asia Regional Office (SEARO), and Western Pacific 
    Regional Office (WPRO) where assistance will be provided. WHO is the 
    appropriate agency to establish collaboration among research groups to 
    improve training, technology transfer and share comparative results.
        The CDC will collaborate in providing: Consultation, scientific and 
    technical assistance and training for transfer of laboratory technology 
    and logistics management for study of epidemiology of pathogenic 
    hantaviruses in the Americas; scientific and technical assistance in 
    the observation of the inactivated vaccine trials in both China and 
    Russia; and training and on-site assistance in technical areas of 
    expertise for investigating the mechanisms of immunity and 
    immunopathology of hantavirus infection in Korea.
    
    Executive Order 12372 Review
    
        This application is not subject to review under Executive Order 
    12372, Intergovernmental Review of Federal Programs.
    
    Public Health System Reporting Requirements
    
        This program is not subject to the Public Health System Reporting 
    Requirements.
    
    Catalog of Federal Domestic Assistance Number
    
        The Catalog of Federal Domestic Assistance Number for this program 
    is 93.283.
    
    Other Requirements
    
    Human Subjects
    
        If the proposed project involves research on human subjects, the 
    applicant must comply with the Department of Health and Human Services 
    Regulations (45 CFR part 46) regarding the protection of human 
    subjects. Assurance must be provided to demonstrate that the project 
    will be subject to initial and continuing review by an appropriate 
    institutional review committee. The applicant will be responsible for 
    providing assurance in accordance with the appropriate guidelines and 
    form provided in the application kit.
    
    Where to Obtain Additional Information
    
        If you are interested in obtaining additional information on this 
    program, please refer to Announcement Number 458 and contact Gordon R. 
    Clapp, Grants Management Specialist, Grants Management Branch, 
    Procurement and Grants Office, Centers for Disease Control and 
    Prevention (CDC), 255 East Paces Ferry Road, NE., Room 314, Mailstop E-
    18, Atlanta, GA 30305, telephone (404) 842-6508.
        A copy of Healthy People 2000 (Full Report: Stock No. 017-001-
    00474-0) or Healthy People 2000 (Summary Report: Stock No. 017-001-
    00473-1), referenced in the SUMMARY section, may be obtained through 
    the Superintendent of Documents, Government Printing Office, 
    Washington, DC 20402-9325, telephone (202) 783-3238.
    
        Dated: July 8, 1994.
    Martha Katz,
    Acting Associate Director for Management and Operations, Centers for 
    Disease Control and Prevention (CDC).
    [FR Doc. 94-17063 Filed 7-13-94; 8:45 am]
    BILLING CODE 4163-18-P
    
    
    

Document Information

Published:
07/14/1994
Department:
Health and Human Services Department
Entry Type:
Uncategorized Document
Document Number:
94-17063
Pages:
0-0 (1 pages)
Docket Numbers:
Federal Register: July 14, 1994, CDC-458